Articles by Jane Wan - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jane Wan

Report from India

Quality assurance of biological products is central to India's good distribution practices guidelines.
Feb 2, 2013

Quality assurance of biological products is central to India's good distribution practices guidelines.

Report from South Korea

Domestic companies are changing their business models in response to recent drug price cuts.
Dec 2, 2012

Domestic companies are changing their business models in response to recent drug price cuts.

Report from India

Foreign firms struggle against stricter patent laws, but all is not lost.
Oct 2, 2012

Foreign firms struggle against stricter patent laws, but all is not lost.

Report from Japan

After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback.
Aug 2, 2012

After a series of government reforms that are appealing to both domestic and foreign players, the Japanese pharmaceutical market is making a comeback.

Report from India

New price-control policy has domestic and global firms waiting on the sidelines to launch products.
Jun 2, 2012

New price-control policy has domestic and global firms waiting on the sidelines to launch products.

Report from China

China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.
Apr 2, 2012

China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.

Report from Asia

Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.
Dec 2, 2011

Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.

Report from Asia

Contract manufacturing organizations throughout Asia are increasing their capabilities to meet market demand and attract foreign investment and partnerships.
Aug 2, 2011

Contract manufacturing organizations throughout Asia are increasing their capabilities to meet market demand and attract foreign investment and partnerships.

Report From China

The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.
Apr 2, 2011

The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here